Abstract
ABSTRACT Tigecycline is regarded as a last-resort treatment for carbapenem-resistant Enterobacteriaceae (CRE), however, the emergence of tigecycline heteroresistance has posted the therapeutic challenge to combat this “nightmare bacteria”. The primary purpose of this study was to demonstrate the existence of tigecycline heteroresistance in carbapenem-resistant E. cloacae (TH-CRECL) and further to explore the epidemiological characteristics and underlying molecular mechanisms. Our study identified a relative low prevalence of carbapenem-resistant E. cloacae (CRECL) isolates, about 20.0% (28/140), as heteroresistance to tigecycline. Molecular genetic relatedness of these heteroresistant isolates were characterized epidemiologically sporadic. In addition, mechanistic analysis revealed that Phe-Arg-β-naphthylamide (PAβN) significantly reversed tigecycline MIC levels of resistant colonies in heteroresistant strains, as primarily related to the marked overproduction of efflux pump genes acrAB and oqxAB, as well as overexpression of transcriptional regulators (soxS and ramA). Moreover, logistic regression analysis showed that previous fluoroquinolone therapy was identified as the only potential independent risk factor for the acquisition of TH-CRECL. Most importantly, our data indicated that patients with TH-CRECL infection might lead to a remarkably prolonged hospital stay and deterioration in functional status. These findings emphasized the necessity of timely detection and intervention of patients infected with TH-CRECL.
Highlights
Enterobacter cloacae (E. cloacae) has been acknowledged as an important and opportunistic pathogen responsible for a broad range of hospital-acquired infections [1]
The rapid increase in these infections caused by carbapenem-resistant E. cloacae (CRECL) has raised growing concern worldwide, which definitely necessitates the availability of ideal antimicrobial agents [2,3,4]
Regarding efflux pump regulator genes, we found that 57.1% (8/ 14) of TH-CRECL isolates were the presence of upregulated ramA gene (10.24–356.7 folds), while three TH-CRECL isolates were observed overexpression of soxS gene in their resistant subpopulations (1.95–4.49 folds)
Summary
Enterobacter cloacae (E. cloacae) has been acknowledged as an important and opportunistic pathogen responsible for a broad range of hospital-acquired infections [1]. The rapid increase in these infections caused by carbapenem-resistant E. cloacae (CRECL) has raised growing concern worldwide, which definitely necessitates the availability of ideal antimicrobial agents [2,3,4]. Tigecycline and colistin exhibit satisfactory activities in vitro against serious infections caused by these pathogens [5]. Tigecycline non-susceptibility in clinical strains could be underestimated when performing the traditional susceptibility testing in vitro, possibly due to heteroresistance, which can be defined as the appearance of a resistant division within entirely susceptible germs. Clinical significance of this phenomenon could be considerable, because less susceptible subpopulations might be picked under antibiotic treatment.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
